Priority Date: 19.04.11 (US 201161477089P)

MONOSPECIFIC AND BISPECIFIC ANTI-IGF-1R AND ANTI-ERBB3 ANTIBODIES

  • Application ID: EP12773950
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) De Clercq & Partners cvba is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 19.04.2011 - Priority Date (US 201161477089P)
  • 26.10.2012 - Publication A2 (WO2012145507)
  • 26.02.2014 - Publication A2 (EP2699602)
  • 01.03.2017 - Publication B1 (EP2699602)